BeOne Medicines Ltd. (ONC)
263.46
-4.71
(-1.76%)
USD |
NASDAQ |
Jun 10, 16:00
263.46
0.00 (0.00%)
After-Hours: 20:00
BeOne Medicines 1 Year Total Returns (Daily) : 1.66% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 1.66% |
| June 08, 2026 | 5.84% |
| June 05, 2026 | 5.10% |
| June 04, 2026 | 8.39% |
| June 03, 2026 | 10.84% |
| June 02, 2026 | 11.69% |
| June 01, 2026 | 13.89% |
| May 29, 2026 | 16.72% |
| May 28, 2026 | 20.87% |
| May 27, 2026 | 25.89% |
| May 26, 2026 | 25.27% |
| May 22, 2026 | 29.94% |
| May 21, 2026 | 30.92% |
| May 20, 2026 | 30.35% |
| May 19, 2026 | 27.27% |
| May 18, 2026 | 28.33% |
| May 15, 2026 | 29.90% |
| May 14, 2026 | 38.50% |
| May 13, 2026 | 40.86% |
| May 12, 2026 | 35.08% |
| May 11, 2026 | 33.95% |
| May 08, 2026 | 32.29% |
| May 07, 2026 | 36.49% |
| May 06, 2026 | 29.60% |
| May 05, 2026 | 17.05% |
| Date | Value |
|---|---|
| May 04, 2026 | 16.17% |
| May 01, 2026 | 14.95% |
| April 30, 2026 | 13.65% |
| April 29, 2026 | 16.43% |
| April 28, 2026 | 19.52% |
| April 27, 2026 | 22.05% |
| April 24, 2026 | 17.43% |
| April 23, 2026 | 20.34% |
| April 22, 2026 | 23.59% |
| April 21, 2026 | 36.25% |
| April 20, 2026 | 37.70% |
| April 17, 2026 | 40.22% |
| April 16, 2026 | 40.57% |
| April 15, 2026 | 33.96% |
| April 14, 2026 | 27.70% |
| April 13, 2026 | 32.68% |
| April 10, 2026 | 48.65% |
| April 09, 2026 | 51.91% |
| April 08, 2026 | 49.08% |
| April 07, 2026 | 37.76% |
| April 06, 2026 | 26.82% |
| April 02, 2026 | 13.10% |
| April 01, 2026 | 13.80% |
| March 31, 2026 | 9.11% |
| March 30, 2026 | 6.24% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| CRISPR Therapeutics AG | 22.31% |
| AC Immune SA | 7.62% |
| Idorsia Ltd. | 209.1% |
| ADC Therapeutics SA | -69.19% |
| MoonLake Immunotherapeutics | -61.82% |